Non-inteRvEntional Study to Observe rAtionaLe to Select add-on TherapY for Type 2 Diabetes Inadequately Controlled With Metformin.

NCT02355145 · clinicaltrials.gov ↗
COMPLETED
Status
1005
Enrollment
INDUSTRY
Sponsor class

Conditions

Sponsor

AstraZeneca